Movement Alert｜XTALPI Rises 5.12% in Regular Trading, JPMorgan Initiates Coverage with Overweight Rating and Target Price of HK$10

Market Focus07-31

On July 31, XTALPI rose 5.12% in regular trading, trading at HK$6.77/share, with turnover of HK$154 million. The stock rebounded after several consecutive days of weakness triggered by a profit warning.

On the news front, JPMorgan recently initiated coverage on XTALPI with an Overweight rating and a target price of HK$10, implying approximately 48% upside from current levels. The bank expressed a positive outlook on the company's diversified business centered on AI-driven drug discovery services and robotic wet laboratories, noting that China's AI pharmaceutical R&D industry is transitioning from commercial exploration toward early commercialization, which may trigger a valuation re-rating.

Within the Life Sciences Tools & Services sector, INSILICO rose 7.09%, GENSCRIPT BIO rose 3.66%, JOINN rose 3.52%, WUXI BIO rose 2.80%, and WUXI APPTEC rose 2.35%, reflecting broad sector recovery that further supported the stock's rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116635504?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 10:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116635504","market":"us","top_or_hot":-1,"title":"Movement Alert｜XTALPI Rises 5.12% in Regular Trading, JPMorgan Initiates Coverage with Overweight Rating and Target Price of HK$10","media":"Market Focus","content":"<p><p>On July 31, XTALPI rose 5.12% in regular trading, trading at HK$6.77/share, with turnover of HK$154 million. The stock rebounded after several consecutive days of weakness triggered by a profit warning.</p><p>On the news front, JPMorgan recently initiated coverage on XTALPI with an Overweight rating and a target price of HK$10, implying approximately 48% upside from current levels. The bank expressed a positive outlook on the company's diversified business centered on AI-driven drug discovery services and robotic wet laboratories, noting that China's AI pharmaceutical R&D industry is transitioning from commercial exploration toward early commercialization, which may trigger a valuation re-rating.</p><p>Within the Life Sciences Tools & Services sector, INSILICO rose 7.09%, GENSCRIPT BIO rose 3.66%, JOINN rose 3.52%, WUXI BIO rose 2.80%, and WUXI APPTEC rose 2.35%, reflecting broad sector recovery that further supported the stock's rebound.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜XTALPI Rises 5.12% in Regular Trading, JPMorgan Initiates Coverage with Overweight Rating and Target Price of HK$10</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜XTALPI Rises 5.12% in Regular Trading, JPMorgan Initiates Coverage with Overweight Rating and Target Price of HK$10\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-31 10:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 31, XTALPI rose 5.12% in regular trading, trading at HK$6.77/share, with turnover of HK$154 million. The stock rebounded after several consecutive days of weakness triggered by a profit warning.</p><p>On the news front, JPMorgan recently initiated coverage on XTALPI with an Overweight rating and a target price of HK$10, implying approximately 48% upside from current levels. The bank expressed a positive outlook on the company's diversified business centered on AI-driven drug discovery services and robotic wet laboratories, noting that China's AI pharmaceutical R&D industry is transitioning from commercial exploration toward early commercialization, which may trigger a valuation re-rating.</p><p>Within the Life Sciences Tools & Services sector, INSILICO rose 7.09%, GENSCRIPT BIO rose 3.66%, JOINN rose 3.52%, WUXI BIO rose 2.80%, and WUXI APPTEC rose 2.35%, reflecting broad sector recovery that further supported the stock's rebound.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1116635504","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116635504","pubTimestamp":1785466350,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 31, XTALPI rose 5.12% in regular trading, trading at HK$6.77/share, with turnover of HK$154 million. The stock rebounded after several consecutive days of weakness triggered by a profit...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"走势警报|XTALPI常规交易上涨5.12%，摩根大通启动跑赢大盘评级覆盖，目标价10港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"On July 31, XTALPI rose 5.12% in regular trading, trading at HK$6.77/share, with turnover of HK$154 million. The stock rebounded after several consecutive days of weakness triggered by a profit warning.On the news front, JPMorgan recently initiated coverage on XTALPI with an Overweight rating and a target price of HK$10, implying approximately 48% upside from current levels. The bank expressed a positive outlook on the company's diversified business centered on AI-driven drug discovery services and robotic wet laboratories, noting that China's AI pharmaceutical R&D industry is transitioning from commercial exploration toward early commercialization, which may trigger a valuation re-rating.Within the Life Sciences Tools & Services sector, INSILICO rose 7.09%, GENSCRIPT BIO rose 3.66%, JOINN rose 3.52%, WUXI BIO rose 2.80%, and WUXI APPTEC rose 2.35%, reflecting broad sector recovery that further supported the stock's rebound.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116635504","isCrawlerRequest":true}